Abstract:Background. Diabetic nephropathy is a common and serious complication of diabetes mellitus (DM) and is one of the leading causes of end-stage renal disease worldwide. Although there have been many investigations on biomarkers for DN, there is no consistent conclusion about reliable biomarkers. The purpose of this study was to perform a systematic review and meta-analysis of the role of circulating retinol-binding protein 4 (RBP4) in the type 2 diabetes mellitus (T2DM) patients with kidney diseases.Materials and Methods. We searched the PubMed, MEDLINE, EMBASE, and Web of Science databases for publications. For the 12 cross-sectional studies that we included in the review, we calculated standard mean differences (SMD) with 95% confidence intervals (CI) for continuous data when the applied scales were different. Risk of bias of included trials was assessed by using the Newcastle-Ottawa Scale.Results. RBP4 concentrations in the micro-, macro-, or micro+macroalbuminuria groups were significantly higher than those in the normal albuminuria group of T2DM patients [P = 0.001, SMD 1.07, 95% CI (0.41, 1.73)]. The estimated glomerular filtration rate (eGFR) was negatively associated with circulating RBP4 concentrations in patients with T2DM [summary Fisher's Z = -0.48, 95% CI (-0.69, -0.26), P < 0.0001]. The albumin-to-creatinine ratio (ACR) was positively associated with circulating RBP4 concentrations in patients with T2DM [summary Fisher's Z=0.20, 95% CI (0.08, 0.32), P=0.001].Conclusion. The levels of circulating RBP4 were significantly higher both in T2DM subjects with micro/macroalbuminuria and in T2DM subjects with declined eGFR. The levels of circulating RBP4 were positively correlated with ACR but negatively correlated with eGFR. Circulating RBP4 could be a reliable biomarker for kidney diseases in T2DM.

Assessment of Retinol Binding Protein 4 in Nutritional Diseases and Liver or Kidney Diseases

Retinol-binding Protein-4 and Nonalcoholic Fatty Liver Disease

Increased Retinol-Free RBP4 Contributes to Insulin Resistance in Gestational Diabetes Mellitus

Relationship between type 2 diabetes and retinol binding protein 4 and its genetic polymorphism

A study on the role of serum Retinol Binding Protein 4 in nonalcoholic fatty liver disease

Serum Retinol Binding Protein 4 and Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus

Retinol binding protein 4 in relation to diet, inflammation, immunity, and cardiovascular diseases

The metabolic role of retinol binding protein 4: an update

Serum Retinol Binding Protein 4 and Cardiovascular Disease

Expression of Retinol Binding Protein 4 in Non-alcoholic Fatty Liver Tissue of Rats

Retinol Binding Protein 4 in CKD Patients with or without Diabetes Mellitus

Recent Progress in Relationship Between RBP4 and Metabolic Syndrome

Diagnostic value of retinol-binding protein 4 in diabetic nephropathy: a systematic review and meta-analysis

The Role Of Circulating Rbp4 In The Type 2 Diabetes Patients With Kidney Diseases: A Systematic Review And Meta-Analysis

Retinol binding protein 4 and type 2 diabetes: from insulin resistance to pancreatic β-cell function

Adipokine Retinol Binding Protein 4 and Cardiovascular Diseases

Serum retinal binding protein 4 in type 2 diabetic retinopathy

Serum Retinol-Binding Protein 4 Levels Are Elevated but Do Not Contribute to Insulin Resistance in Newly Diagnosed Chinese Hypertensive Patients

Circulating Retinol-Binding Protein 4 is Associated with the Development and Regression of Non-Alcoholic Fatty Liver Disease.

Retinol Binding Protein-4 Levels and Non-alcoholic Fatty Liver Disease: A Community-Based Cross-Sectional Study

Retinol-Binding Protein 4 Induces Hepatic Mitochondrial Dysfunction and Promotes Hepatic Steatosis